WELLBUTRIN Safety Questions, WELLBUTRIN Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about WELLBUTRIN. Our extensive database of WELLBUTRIN adverse events and WELLBUTRIN warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about WELLBUTRIN

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet



WELLBUTRIN Safety Reports

Total WELLBUTRIN reports: 1696.
WELLBUTRIN FDA safety alerts: 2004 2005 .
Reported deaths: 122    Reported hospitalizations: 185.
Take WELLBUTRIN Side Effects Survey or Share Your WELLBUTRIN Story. WELLBUTRIN Usage.

Showing 1-75 of 1696 Next >

Consumer or non-health professional from UNITED STATES reported WELLBUTRIN problem on June 22, 2006. Female patient, 53 years of age, was diagnosed with chronic fatigue syndrome and was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, depressed mood, depression. WELLBUTRIN dosage: unknown. During the same period patient was treated with PROVIGIL, ATENOLOL, LUNESTA, PAXIL, PARAFONTE. Patient recovered.

WELLBUTRIN problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 25, 2006. Female patient, 55 years of age, was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: constipation, gingival bleeding, stomatitis, vomiting. WELLBUTRIN dosage: unknown. During the same period patient was treated with NICORETTE, NICOTINE POLACRILEX. Patient recovered.

Consumer or non-health professional from UNITED STATES reported WELLBUTRIN problem on Apr 26, 2006. Female patient, 49 years of age, was diagnosed with depression and was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: suicidal ideation. WELLBUTRIN dosage: unknown. During the same period patient was treated with DIPRIVAN. Patient recovered.

WELLBUTRIN problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 26, 2006. Female patient, weighting 139.3 lb, was diagnosed with depression and was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: blepharospasm. WELLBUTRIN dosage: 150MG PER DAY. During the same period patient was treated with CYMBALTA. Patient recovered.

Consumer or non-health professional from UNITED STATES reported WELLBUTRIN problem on Apr 28, 2006. Female patient, 60 years of age, was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: adverse event, ill-defined disorder, stress at work. WELLBUTRIN dosage: unknown. Patient recovered.

WELLBUTRIN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 10, 2006. Male patient, 51 years of age, weighting 200.4 lb, was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: hallucination. WELLBUTRIN dosage: unknown. During the same period patient was treated with PEGASYS, COPEGUS, HYDROCODONE BITARTRATE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported WELLBUTRIN problem on May 08, 2006. Female patient, 46 years of age, was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: convulsion. WELLBUTRIN dosage: unknown. During the same period patient was treated with REBIF. Patient recovered.

WELLBUTRIN problem was reported by a Consumer or non-health professional from UNITED STATES on May 09, 2006. Female patient was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: alopecia. WELLBUTRIN dosage: 300MG PER DAY. Patient recovered.

Consumer or non-health professional from UNITED STATES reported WELLBUTRIN problem on May 15, 2006. Female patient, weighting 110.2 lb, was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: alopecia. WELLBUTRIN dosage: unknown. Patient recovered.

WELLBUTRIN problem was reported by a Consumer or non-health professional from UNITED STATES on May 11, 2006. Female patient, 56 years of age, was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: aphasia. WELLBUTRIN dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported WELLBUTRIN problem on May 23, 2006. Male patient, 45 years of age, was diagnosed with tobacco abuse and was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: tobacco abuse. WELLBUTRIN dosage: unknown. Patient recovered.

WELLBUTRIN problem was reported by a Consumer or non-health professional from UNITED STATES on May 24, 2006. Male patient, 28 years of age, was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: red blood cell count decreased, white blood cell count decreased. WELLBUTRIN dosage: 150MG TWICE PER DAY. During the same period patient was treated with DEPAKOTE, LIPITOR, ATENOLOL, AMBIEN, MINOCYCLINE, CLARITIN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported WELLBUTRIN problem on May 16, 2006. Female patient, 75 years of age, was diagnosed with anxiety, hypertension and was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: anxiety, fear, feeling abnormal, feeling jittery, nervousness. WELLBUTRIN dosage: 175MG PER DAY. During the same period patient was treated with TOPROL, LEXAPRO. Patient recovered.

WELLBUTRIN problem was reported by a Consumer or non-health professional from UNITED STATES on May 31, 2006. Male patient, 23 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: visual disturbance. WELLBUTRIN dosage: 375MG PER DAY. Patient recovered.

Consumer or non-health professional from UNITED STATES reported WELLBUTRIN problem on June 12, 2006. Female patient, 56 years of age, was diagnosed with depression and was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: depression, heart rate increased. WELLBUTRIN dosage: 150MG PER DAY. During the same period patient was treated with STRATTERA. Patient recovered.

WELLBUTRIN problem was reported by a Physician from UNITED STATES on July 10, 2006. Female patient, 14 years of age, weighting 110.2 lb, was diagnosed with anxiety and was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: grand mal convulsion, incontinence, postictal state. WELLBUTRIN dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported WELLBUTRIN problem on June 13, 2006. Female patient, 45 years of age, was diagnosed with depression and was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: insomnia. WELLBUTRIN dosage: 75MG THREE TIMES PER DAY. Patient recovered.

WELLBUTRIN problem was reported by a Consumer or non-health professional from UNITED STATES on June 15, 2006. Female patient, 49 years of age, was diagnosed with cough and was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: anorexia, dizziness, speech disorder. WELLBUTRIN dosage: unknown. During the same period patient was treated with DELSYM, AVELOX, ALLEGRA. Patient recovered.

Consumer or non-health professional from UNITED STATES reported WELLBUTRIN problem on June 15, 2006. Male patient, 58 years of age, was diagnosed with depression and was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, amnesia, confusional state, depression, disturbance in attention. WELLBUTRIN dosage: 75MG FOUR TIMES PER DAY. During the same period patient was treated with BUPROPION HYDROCHLORIDE, CYMBALTA, NEURONTIN, LORAZEPAM, PLAVIX, LOPRESSOR, LISINOPRIL. Patient recovered.

WELLBUTRIN problem was reported by a Consumer or non-health professional from UNITED STATES on June 19, 2006. Female patient, 55 years of age, was diagnosed with depression and was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: convulsion. WELLBUTRIN dosage: unknown. During the same period patient was treated with BENZODIAZEPINE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported WELLBUTRIN problem on June 20, 2006. Male patient, 89 years of age, was diagnosed with depression and was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: anorexia, asthenia, decreased appetite, tremor. WELLBUTRIN dosage: unknown. Patient recovered.

WELLBUTRIN problem was reported by a Consumer or non-health professional from UNITED STATES on June 21, 2006. Male patient, 39 years of age, was diagnosed with depression and was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: mouth ulceration, pharyngeal hypoaesthesia, vomiting. WELLBUTRIN dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported WELLBUTRIN problem on June 21, 2006. Male patient, 38 years of age, was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: convulsion, dyskinesia, grand mal convulsion. WELLBUTRIN dosage: 100MG PER DAY. Patient recovered.

WELLBUTRIN problem was reported by a Consumer or non-health professional from UNITED STATES on June 22, 2006. Male patient was diagnosed with anxiety and was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: agitation, dizziness, nausea, photopsia. WELLBUTRIN dosage: 150MG PER DAY. During the same period patient was treated with LIPITOR. Patient recovered.

Consumer or non-health professional from UNITED STATES reported WELLBUTRIN problem on July 07, 2006. Female patient, 72 years of age, weighting 152.3 lb, was diagnosed with depression and was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: dizziness, ecchymosis, headache, hyperhidrosis, nausea, pruritus, rash, urticaria, vomiting. WELLBUTRIN dosage: 150MG PER DAY. During the same period patient was treated with DEPAKOTE, LITHIUM CARBONATE, LEVOTHYROXINE. Patient recovered.

WELLBUTRIN problem was reported by a Consumer or non-health professional from UNITED STATES on June 30, 2006. Female patient was diagnosed with depression and was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: convulsion. WELLBUTRIN dosage: 300MG PER DAY. Patient recovered.

Consumer or non-health professional from UNITED STATES reported WELLBUTRIN problem on July 05, 2006. Female patient, weighting 165.3 lb, was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: convulsion. WELLBUTRIN dosage: unknown. Patient recovered.

WELLBUTRIN problem was reported by a Consumer or non-health professional from UNITED STATES on July 05, 2006. Male patient, 66 years of age, was diagnosed with depression and was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: anxiety, fatigue, lethargy, weight decreased. WELLBUTRIN dosage: 75MG PER DAY. During the same period patient was treated with XANAX, ACETYLCARNITINE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported WELLBUTRIN problem on July 25, 2006. Female patient, 39 years of age, weighting 350.8 lb, was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: grand mal convulsion, incontinence, tongue biting. WELLBUTRIN dosage: 150MG TWICE PER DAY. During the same period patient was treated with CYMBALTA. Patient recovered.

WELLBUTRIN problem was reported by a Consumer or non-health professional from UNITED STATES on July 11, 2006. Female patient was diagnosed with depression and was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: disturbance in attention, somnolence. WELLBUTRIN dosage: 300MG PER DAY. During the same period patient was treated with BIRTH CONTROL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported WELLBUTRIN problem on July 18, 2006. Female patient, 25 years of age, was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: alopecia. WELLBUTRIN dosage: unknown. Patient recovered.

WELLBUTRIN problem was reported by a Consumer or non-health professional from UNITED STATES on July 18, 2006. Female patient, 77 years of age, was diagnosed with depression and was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: vomiting. WELLBUTRIN dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported WELLBUTRIN problem on Aug 04, 2006. Female patient, 59 years of age, was diagnosed with depression and was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: convulsion. WELLBUTRIN dosage: unknown. During the same period patient was treated with AVONEX. Patient recovered.

WELLBUTRIN problem was reported by a Consumer or non-health professional from UNITED STATES on July 21, 2006. Female patient was diagnosed with depression and was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: panic attack. WELLBUTRIN dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported WELLBUTRIN problem on July 24, 2006. Female patient was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: smoker. WELLBUTRIN dosage: 150MG TWICE PER DAY. Patient recovered.

WELLBUTRIN problem was reported by a Consumer or non-health professional from UNITED STATES on July 20, 2006. Female patient, 50 years of age, was diagnosed with depression and was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: palpitations. WELLBUTRIN dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported WELLBUTRIN problem on July 26, 2006. Male patient, 42 years of age, was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: rash. WELLBUTRIN dosage: unknown. Patient recovered.

WELLBUTRIN problem was reported by a Consumer or non-health professional from UNITED STATES on July 28, 2006. Female patient, 59 years of age, was diagnosed with depression and was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: convulsion. WELLBUTRIN dosage: unknown. During the same period patient was treated with AVONEX. Patient recovered.

Consumer or non-health professional from UNITED STATES reported WELLBUTRIN problem on July 31, 2006. Female patient, 70 years of age, was diagnosed with depression and was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: headache. WELLBUTRIN dosage: 75MG PER DAY. Patient recovered.

WELLBUTRIN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 02, 2006. Female patient, 67 years of age, was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: alopecia. WELLBUTRIN dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported WELLBUTRIN problem on Aug 24, 2006. Female patient, 55 years of age, was diagnosed with anxiety and was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: mental status changes, tardive dyskinesia. WELLBUTRIN dosage: unknown. During the same period patient was treated with LIPITOR, LEVOXYL. Patient recovered.

WELLBUTRIN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 02, 2006. Female patient, 60 years of age, was diagnosed with depression and was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: convulsion. WELLBUTRIN dosage: unknown. During the same period patient was treated with PROZAC. Patient recovered.

Consumer or non-health professional from UNITED STATES reported WELLBUTRIN problem on July 31, 2006. Female patient was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: depression. WELLBUTRIN dosage: 300MG PER DAY. Patient recovered.

WELLBUTRIN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 04, 2006. Male patient, 61 years of age, was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: erectile dysfunction, ill-defined disorder, libido decreased. WELLBUTRIN dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported WELLBUTRIN problem on Aug 24, 2006. Female patient, 28 years of age, was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: paranoia, psychotic disorder. WELLBUTRIN dosage: 100MG PER DAY. During the same period patient was treated with ORAL CONTRACEPTIVE. Patient recovered.

WELLBUTRIN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 11, 2006. Male patient, 26 years of age, was diagnosed with depression and was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: insomnia. WELLBUTRIN dosage: unknown. During the same period patient was treated with ADDERALL, CLONAZEPAM. Patient recovered.

Consumer or non-health professional from UNITED STATES reported WELLBUTRIN problem on Aug 15, 2006. Male patient, 60 years of age, was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: agitation, balance disorder, insomnia. WELLBUTRIN dosage: 300MG PER DAY. During the same period patient was treated with PROZAC. Patient recovered.

WELLBUTRIN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 17, 2006. Male patient was diagnosed with depression and was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: insomnia. WELLBUTRIN dosage: 300MG PER DAY. Patient recovered.

Consumer or non-health professional from UNITED STATES reported WELLBUTRIN problem on Aug 18, 2006. Female patient, 24 years of age, was diagnosed with depression and was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: insomnia, irritability. WELLBUTRIN dosage: unknown. During the same period patient was treated with BUSPAR, RISPERDAL. Patient recovered.

WELLBUTRIN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 22, 2006. Female patient, 45 years of age, was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: asthenia, fatigue, headache, nausea. WELLBUTRIN dosage: unknown. During the same period patient was treated with NICOTROL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported WELLBUTRIN problem on Aug 28, 2006. Female patient, 44 years of age, was diagnosed with depression and was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: convulsion, hyperhidrosis, insomnia, irritability. WELLBUTRIN dosage: unknown. During the same period patient was treated with PROTONIX, BIRTH CONTROL. Patient recovered.

WELLBUTRIN problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 08, 2006. Female patient, 62 years of age, was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: urinary retention. WELLBUTRIN dosage: unknown. During the same period patient was treated with PROTONIX. Patient recovered.

Consumer or non-health professional from UNITED STATES reported WELLBUTRIN problem on Sept 05, 2006. Male patient, 70 years of age, was diagnosed with depression and was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: tremor. WELLBUTRIN dosage: 100MG PER DAY. During the same period patient was treated with PROPRANOLOL, TRICOR, HYDROCHLOROTHIAZIDE, LITHIUM CARBONATE, ASPIRIN, SYNTHROID. Patient recovered.

WELLBUTRIN problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 07, 2006. Male patient, 27 years of age, was diagnosed with depression and was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: intentional overdose. WELLBUTRIN dosage: 150MG TWICE PER DAY. During the same period patient was treated with NARCEINE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported WELLBUTRIN problem on Sept 19, 2006. Female patient was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: prescribed overdose. WELLBUTRIN dosage: 450MG PER DAY. Patient recovered.

WELLBUTRIN problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 04, 2006. Female patient, 35 years of age, weighting 184.3 lb, was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: emotional disorder. WELLBUTRIN dosage: unknown. Patient recovered.

Health Professional from UNITED STATES reported WELLBUTRIN problem on Oct 03, 2006. Female patient, 27 years of age, weighting 155.4 lb, was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: feeling jittery, mental impairment, vision blurred, visual disturbance. WELLBUTRIN dosage: unknown. Patient recovered.

WELLBUTRIN problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 21, 2006. Male patient was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: feeling jittery. WELLBUTRIN dosage: 300MG PER DAY. Patient recovered.

Consumer or non-health professional from UNITED STATES reported WELLBUTRIN problem on Sept 25, 2006. Female patient, 57 years of age, was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: dizziness, feeling abnormal. WELLBUTRIN dosage: unknown. Patient recovered.

WELLBUTRIN problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 25, 2006. Female patient, 19 years of age, was diagnosed with depression and was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: affect lability, agitation, depression. WELLBUTRIN dosage: 450MG PER DAY. During the same period patient was treated with YASMIN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported WELLBUTRIN problem on Sept 25, 2006. Male patient was diagnosed with panic attack and was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: agitation, dizziness, heart rate increased, insomnia, panic attack, tinnitus. WELLBUTRIN dosage: 300MG PER DAY. Patient recovered.

WELLBUTRIN problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 29, 2006. Male patient, 64 years of age, was diagnosed with depression and was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: agitation, anxiety, change of bowel habit, chills, gastric disorder, insomnia. WELLBUTRIN dosage: 75MG PER DAY. During the same period patient was treated with NORVASC. Patient recovered.

Consumer or non-health professional from UNITED STATES reported WELLBUTRIN problem on Sept 29, 2006. Female patient, 54 years of age, was diagnosed with depression, migraine prophylaxis, anxiety and was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: anxiety, suicidal ideation. WELLBUTRIN dosage: unknown. During the same period patient was treated with KEPPRA, ALPRAZOLAM. Patient recovered.

WELLBUTRIN problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 03, 2006. Female patient, 45 years of age, was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: nicotine dependence. WELLBUTRIN dosage: unknown. During the same period patient was treated with NICORETTE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported WELLBUTRIN problem on Oct 03, 2006. Female patient, 45 years of age, was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: tinnitus. WELLBUTRIN dosage: unknown. During the same period patient was treated with REBIF. Patient recovered.

WELLBUTRIN problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 06, 2006. Female patient, 26 years of age, was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: dizziness. WELLBUTRIN dosage: unknown. During the same period patient was treated with REBIF. Patient recovered.

Consumer or non-health professional from UNITED STATES reported WELLBUTRIN problem on Oct 13, 2006. Female patient, 55 years of age, was diagnosed with depression and was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: crying. WELLBUTRIN dosage: 150MG PER DAY. Patient recovered.

WELLBUTRIN problem was reported by a Physician from UNITED STATES on Oct 12, 2006. Female patient was diagnosed with depression and was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: anxiety, insomnia. WELLBUTRIN dosage: 100MG THREE TIMES PER DAY. During the same period patient was treated with STEROIDS. Patient recovered.

Consumer or non-health professional from UNITED STATES reported WELLBUTRIN problem on Oct 31, 2006. Female patient was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: depressed mood, depression, suicidal ideation. WELLBUTRIN dosage: 150MG TWICE PER DAY. Patient recovered.

WELLBUTRIN problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 20, 2006. Female patient, 78 years of age, was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: muscular weakness, myalgia. WELLBUTRIN dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported WELLBUTRIN problem on Nov 21, 2006. Female patient, weighting 125.2 lb, was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: decreased appetite, ear infection, hypertension, pharyngolaryngeal pain. WELLBUTRIN dosage: unknown. Patient recovered.

WELLBUTRIN problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 27, 2006. Female patient was diagnosed with depression and was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: nervousness, poor quality sleep. WELLBUTRIN dosage: 75MG THREE TIMES PER DAY. During the same period patient was treated with NICODERM CQ, DEPAKOTE, SLEEPING S, KLONOPIN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported WELLBUTRIN problem on Nov 28, 2006. Female patient, 45 years of age, was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: convulsion. WELLBUTRIN dosage: unknown. Patient was hospitalized. Patient recovered.

WELLBUTRIN problem was reported by a Health Professional from UNITED STATES on Jan 23, 2007. Female patient, 24 years of age, weighting 188.5 lb, was diagnosed with depressive symptom, acne and was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: aggression, agitation, confusional state, depressed mood, depression, disorientation, electrocardiogram qt prolonged, electrocardiogram t wave abnormal, fatigue. WELLBUTRIN dosage: 300MG IN THE MORNING. During the same period patient was treated with TETRACYCLINE, VITAMIN A, ALCOHOL, DIFFERIN, VITAMIN A. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported WELLBUTRIN problem on Jan 24, 2007. Male patient, 65 years of age, was diagnosed with depression, tachyarrhythmia, diabetes mellitus and was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: flushing, myocardial infarction. WELLBUTRIN dosage: 300MG PER DAY. During the same period patient was treated with LANOXIN, NIASPAN, TRAZODONE, TENORMIN, GLUCOPHAGE, GLUCOTROL, ACTOS, TRICOR. Patient died on 06/11/2006.

Showing 1-75 of 1696 Next >

Ask Our Patient Community about WELLBUTRIN

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z
This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert (aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol
Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol
Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

 F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
HaloperidolThis drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant
Insulin Glulisine recombinant
Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
LinezolidThis drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert
Naratriptan
Nesiritide recombinant
Nateglinide
Natrecor (nesiritide recombinant)
NefazodoneThis drug has as active FDA Safety Alert
Nelarabine
NeoTect Kit (technetium Tc 99m depreotide)
Nesiritide recombinant
NeurontinThis drug has as active FDA Safety Alert (gabapentin)
Nexavar (sorafenib)
Nitazoxanide
Nitisinone
Norelgestromin
NovoLog (insulin aspart recombinant)
Noxafil (posaconazole)

back to top

O
Olanzapine
Olanzapine/fluoxetineThis drug has as active FDA Safety Alert
Olmesartan medoxomil
Omacor (omega-3-acid ethyl esters)
OmalizumabThis drug has as active FDA Safety Alert
Omega-3-acid ethyl esters
Omnaris (cirlesonide)
OmniscanThis drug has as active FDA Safety Alert (gadodiamide)
OptiMARK (gadoversetamide)
Optison (perflutren protein-type A microspheres)
Orencia (abatacept)
Orfadin (nitisinone)
Orlistat
Ortho Evra (norelgestromin; ethinyl estradiol)
Oseltamivir phosphate
OsmoprepThis drug has as active FDA Safety Alert (sodium phosphate)
Oxaliplatin
OxcarbazepineThis drug has as active FDA Safety Alert


back to top

P
PaceroneThis drug has as active FDA Safety Alert (amiodarone)
Palifermin
Paliperidone
PamidronateThis drug has as active FDA Safety Alert
Panitumumab
Panretin Gel (alitretinoin)
Pantoprazole
Paricalcitol
ParoxetineThis drug has as active FDA Safety Alert
PaxilThis drug has as active FDA Safety Alert (paroxetine)
Pegaptanib
Pegvisomant
Pemetrexed
PemolineThis drug has as active FDA Safety Alert
Pentobarbital and carbromal
Perflutren lipid microspheres
PerindoprilThis drug has as active FDA Safety Alert
PhenerganThis drug has as active FDA Safety Alert (promethazine)
Pimecrolimus
PioglitazoneThis drug has as active FDA Safety Alert
Placidyl (ethchlorvynol)
Plan B (levonorgestrel)
Pletal (cilostazol)
Poractant alfa
Posaconazole
Pramlintide Acetate
Precedex (dexmedetomidine)
PregabalinThis drug has as active FDA Safety Alert
Prezista (darunavir)
Prialt (ziconotide)
Priftin (rifapentine)
PrinivilThis drug has as active FDA Safety Alert (lisinopril)
ProcritThis drug has as active FDA Safety Alert (epoetin alfa)
ProHanceThis drug has as active FDA Safety Alert (gadoteridol)
PromethazineThis drug has as active FDA Safety Alert
PropofolThis drug has as active FDA Safety Alert
Prosom (estazolam)
Protonix (pantoprazole)
Protopic (tacrolimus)
Provigil (modafinil)
ProzacThis drug has as active FDA Safety Alert (fluoxetine)
Prussian blue


back to top

 Q
Quazepam
Quetiapine
QuinaprilThis drug has as active FDA Safety Alert
Quinupristin

R
Rabeprazole
Radiogardase (prussian blue)
Ramelteon
RamiprilThis drug has as active FDA Safety Alert
Ranexa (ranolazine)
Ranibizumab
Ranolazine
Rapamune (sirolimus)
Raptiva (efalizumab)
Rasagiline
Razadyne